PWS
IBB icon

Private Wealth Strategies’s iShares Biotechnology ETF IBB Stock Holding History

Private Wealth Strategies’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,848
Closed -$940K – 75
2024
Q1 		$940K Buy
6,848
+6
+0.1% +$819 0.2% 23
2023
Q4 		$930K Sell
6,842
-1,205
-15% -$147K 0.21% 26
2023
Q3 		$984K Hold
8,047
– – 0.25% 22
2023
Q2 		$1.02M Hold
8,047
– – 0.25% 24
2023
Q1 		$1.04M Buy
8,047
+3
+0% +$393 0.26% 24
2022
Q4 		$1.06M Buy
8,044
+6
+0.1% +$775 0.28% 23
2022
Q3 		$940K Buy
8,038
+8
+0.1% +$993 0.27% 23
2022
Q2 		$945K Buy
8,030
+2
+0% +$237 0.26% 32
2022
Q1 		$1.05M Buy
8,028
+7
+0.1% +$912 0.26% 30
2021
Q4 		$1.22M Buy
8,021
+2
+0% +$310 0.28% 30
2021
Q3 		$1.3M Buy
8,019
+5
+0.1% +$841 0.32% 29
2021
Q2 		$1.31M Buy
8,014
+1
+0% +$154 0.34% 30
2021
Q1 		$1.21M Buy
8,013
+6
+0.1% +$953 0.33% 30
2020
Q4 		$1.21M Sell
8,007
-7,887
-50% -$1.13M 0.37% 30
2020
Q3 		$2.15M Buy
15,894
+7
+0% +$950 0.75% 25
2020
Q2 		$2.17M Sell
15,887
-4,512
-22% -$575K 0.96% 22
2020
Q1 		$2.2M Sell
20,399
-2,082
-9% -$240K 1.1% 22
2019
Q4 		$2.71M Buy
+22,481
New +$2.51M 1.08% 17

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Private Wealth Strategies's IBB Position: Q2 2024 in Review

Private Wealth Strategies sold out of iShares Biotechnology ETF (IBB) in Q2 2024, closing a stake of 6,848 shares — an estimated $940K sold.

Private Wealth Strategies first reported a position in IBB in Q4 2019 and held it in 18 quarters. The position peaked at $2.71M in Q4 2019. 894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

  • Private Wealth Strategies reported no remaining iShares Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
  • Private Wealth Strategies sold 6,848 iShares Biotechnology ETF shares in Q2 2024, an estimated $940K.
  • Private Wealth Strategies first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 18 quarters.
  • Private Wealth Strategies's iShares Biotechnology ETF position peaked at $2.71M in Q4 2019.
  • 894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on Private Wealth Strategies's 13F filing for Q2 2024, filed 1 Aug 2024.